Related Experiment Video
Updated: Dec 7, 2025
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations
Carlos E Sanchez1, Ehsan P Dowlati2, Ashley E Geiger1
1Program for Cell Enhancement and Technologies for Immunotherapy and Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC.
Abstract:
Natural killer (NK) cells, the primary effector cells of the innate immune system, utilize multiple strategies to recognize tumor cells by (1) detecting the presence of activating receptor ligands, which are often upregulated in cancer; (2) targeting cells that have a loss of major histocompatibility complex (MHC); and (3) binding to antibodies that bind to tumor-specific antigens on the tumor cell surface. All these strategies have been successfully harnessed in adoptive NK cell immunotherapies targeting cancer. In this review, we review the applications of NK cell therapies across different tumor types. Similar to other forms of immunotherapy, tumor-induced immune escape and immune suppression can limit NK cell therapies' efficacy. Therefore, we also discuss how these limitations can be overcome by conferring NK cells with the ability to redirect their tumor-targeting capabilities and survive the immune-suppressive tumor microenvironment. Finally, we also discuss how future iterations can benefit from combination therapies with other immunotherapeutic agents.
Insights
Natural killer (NK) cell immunotherapies harness innate immunity to target cancer by recognizing tumor cells through activating ligands, MHC loss, or antibody binding. Strategies to overcome immune suppression enhance NK cell therapy efficacy.
Area of Science:
- Immunology
- Oncology
- Cell Therapy
Background:
- Natural killer (NK) cells are key innate immune effectors targeting tumor cells.
- NK cell recognition involves activating ligands, MHC loss, and antibody-dependent cellular cytotoxicity.
- Adoptive NK cell immunotherapy leverages these mechanisms for cancer treatment.
Purpose of the Study:
- To review the applications of NK cell therapies across various tumor types.
- To discuss challenges in NK cell therapy, including immune escape and suppression.
- To explore strategies for overcoming these limitations and enhancing therapeutic efficacy.
Main Methods:
- Review of current literature on NK cell immunotherapy in cancer.
- Analysis of NK cell recognition mechanisms and their therapeutic exploitation.
- Discussion of methods to enhance NK cell survival and function in the tumor microenvironment.
Main Results:
- NK cell therapies show promise across diverse cancer types.
- Tumor-induced immune suppression and escape are significant limitations.
- Strategies to redirect NK cell targeting and improve survival are being developed.
Conclusions:
- Adoptive NK cell immunotherapy is a viable strategy for cancer treatment.
- Overcoming the tumor microenvironment's suppressive effects is crucial for efficacy.
- Combination therapies hold potential for future advancements in NK cell-based cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...